Latest Shareholder Approvals News

EVE Health Group has completed its acquisition of Nextract Pty Ltd, positioning itself to enter the lucrative erectile dysfunction and dysmenorrhea markets with innovative drug delivery technologies.

Kinetiko Energy has completed a $2.2 million placement, supported by directors and major shareholders, to advance its gas exploration and production testing in South Africa’s Mpumalanga Province. Initial production test results are expected in July 2025.

Australian Critical Minerals has agreed to acquire Circuit Resources, gaining a substantial portfolio of gold, copper, silver, zinc, lead, and lithium projects in Peru, unlocking immediate drill-ready targets with significant exploration upside.

dorsaVi has secured exclusive worldwide rights to cutting-edge RRAM technology from NTU Singapore, promising to revolutionize its wearable sensor products with enhanced performance and energy efficiency. This strategic move positions the company for expansion into healthcare, elite sports, and industrial IoT markets.

AdNeo Limited has completed a $5.5 million equity placement and announced a transformational acquisition of Learnt Global, doubling its revenue and significantly reducing debt to position itself as a leader in Australia’s vocational education technology sector.

SSH Group has raised $2.75 million in a placement anchored by mining sector heavyweight Ross Stewart Norgard, aiming to accelerate its mining services expansion in Western Australia.

McLaren Minerals has successfully raised $1.282 million through a two-tranche placement to advance its McLaren Titanium Project in Western Australia, aiming to complete a critical pre-feasibility study by early Q3 2025.

L1 Capital and its associates, holding nearly 17% of Platinum Capital, oppose the proposed restructure into an ETF, while the Board urges shareholders to approve the scheme.

Marimaca Copper has successfully closed the first tranche of a C$24.4 million private placement, backing its flagship Chilean copper project. The funding round includes significant participation from related parties, setting the stage for accelerated exploration and development.

Nanoveu Limited has locked in a $500,000 funding guarantee through an options underwriting agreement, underpinning its push to commercialise cutting-edge semiconductor and 3D visualisation technologies.

EVE Health Group has launched a $1.5 million capital raise alongside the acquisition of biotech firm Nextract, aiming to expand its footprint in health and pharmaceutical products focused on erectile dysfunction and period pain.

Spartan Resources has dispatched the crucial transaction booklet to shareholders detailing Ramelius Resources’ proposed acquisition, with the Spartan Board unanimously recommending support for the deal.